https://www.psychiatrictimes.com/schizophrenia/cannabidiol-adjunctive-treatment-schizophrenia
The potential beneficial effects of CBD on cognition in patients with schizophrenia have critical importance, since cognitive deficits are common in schizophrenia (up to 75%-85% of patients), usually precede other symptoms, and respond minimally to the available pharmacological treatments.